MD1139G2 - Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase - Google Patents

Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase

Info

Publication number
MD1139G2
MD1139G2 MD95-0171A MD950171A MD1139G2 MD 1139 G2 MD1139 G2 MD 1139G2 MD 950171 A MD950171 A MD 950171A MD 1139 G2 MD1139 G2 MD 1139G2
Authority
MD
Moldova
Prior art keywords
pharmaceutical
agitation
states
depression
treatment
Prior art date
Application number
MD95-0171A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD1139F2 (en
MD950171A (en
Inventor
Schneider Werner
F. Elstner Erich
Kleber Elisabeth
Original Assignee
Steigerwald Arzneimittelwerk Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steigerwald Arzneimittelwerk Gmbh filed Critical Steigerwald Arzneimittelwerk Gmbh
Publication of MD950171A publication Critical patent/MD950171A/xx
Publication of MD1139F2 publication Critical patent/MD1139F2/xx
Publication of MD1139G2 publication Critical patent/MD1139G2/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/50—Fumariaceae (Fumitory family), e.g. bleeding heart
    • A61K36/505—Corydalis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MD95-0171A 1991-07-09 1994-12-30 Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase MD1139G2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4122706A DE4122706C1 (enExample) 1991-07-09 1991-07-09

Publications (3)

Publication Number Publication Date
MD950171A MD950171A (en) 1996-06-28
MD1139F2 MD1139F2 (en) 1999-01-31
MD1139G2 true MD1139G2 (ro) 1999-10-31

Family

ID=6435763

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0171A MD1139G2 (ro) 1991-07-09 1994-12-30 Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase

Country Status (26)

Country Link
US (1) US5308619A (enExample)
EP (1) EP0535317B1 (enExample)
JP (1) JPH085796B2 (enExample)
KR (1) KR100225010B1 (enExample)
AT (1) ATE139446T1 (enExample)
AU (1) AU652262B2 (enExample)
CA (1) CA2072950A1 (enExample)
CZ (1) CZ279915B6 (enExample)
DE (2) DE4122706C1 (enExample)
DK (1) DK0535317T3 (enExample)
EE (1) EE03169B1 (enExample)
EG (1) EG20140A (enExample)
ES (1) ES2088053T3 (enExample)
GR (1) GR3020289T3 (enExample)
HU (1) HUT61668A (enExample)
IE (1) IE74691B1 (enExample)
IL (1) IL102410A (enExample)
MD (1) MD1139G2 (enExample)
MX (1) MX9204011A (enExample)
PT (1) PT100668B (enExample)
RU (1) RU2072859C1 (enExample)
SI (1) SI9200138A (enExample)
SK (1) SK279531B6 (enExample)
UA (1) UA26971C2 (enExample)
YU (1) YU48554B (enExample)
ZA (1) ZA925059B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5460819A (en) * 1991-12-13 1995-10-24 Children's Medical Center Corporation Method for treating PQQ-responsive heavy metal toxicity
FR2743721B1 (fr) * 1996-01-19 1998-04-03 Innothera Lab Sa Association mineralo-phytotherapique sous forme galenique unitaire de comprimes
PT1066042E (pt) * 1998-03-26 2006-12-29 Phytopharm Plc Saponinas esteroides para o tratamento de doença de alzheimer
NZ514253A (en) 1999-03-11 2003-06-30 Zeachem Inc Process for producing ethanol
US7074603B2 (en) * 1999-03-11 2006-07-11 Zeachem, Inc. Process for producing ethanol from corn dry milling
US6521634B2 (en) 2001-03-28 2003-02-18 The Hong Kong University Of Science & Technology Uses of dl-THP
KR20030063735A (ko) * 2002-01-23 2003-07-31 주식회사 석산터메디칼 신경성 질환 예방 및 치료를 위한 약제학적 조성물 및,실험용 동물에 신경성 질환을 일으키는 방법
US7341745B2 (en) * 2003-02-07 2008-03-11 Arizona Health Consulting, Llc Method for decreasing nicotine and other substance use in humans
NZ586246A (en) * 2004-01-29 2013-03-28 Zeachem Inc Recovery of organic acids from a fermentation broth
FR2878163B1 (fr) * 2004-11-25 2007-04-27 R & D Pharma Nouvelles compositions pharmaceutiques a visee phytotherapeutique

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR961M (enExample) * 1961-03-03 1961-11-27
DE1467868A1 (de) * 1964-10-20 1969-01-30 Dainippon Pharmaceutical Co Verfahren zur Herstellung eines gegen Geschwuere des Verdauungstraktes wirksamen Medikamentes
JPS60181023A (ja) * 1984-02-28 1985-09-14 Nitto Electric Ind Co Ltd 漢方局所麻酔性組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
H. A. Hoppe, "Drogenkunde", vol. 1, 8 ed., 1975, Walter de Gruyter (DE), p. 345-346 şi 472. *
H. Hendriks H. et al. Planta medica, 1982, vol. 45, p.2 *
R. F. Wess, "Lehrbuch der Phytotherapie", 6 ed., 1985, Stuttgart (DE), p. 356 şi 357 *

Also Published As

Publication number Publication date
EG20140A (en) 1997-07-31
GR3020289T3 (en) 1996-09-30
EE03169B1 (et) 1999-04-15
IE922226A1 (en) 1993-01-13
PT100668B (pt) 1999-08-31
ES2088053T3 (es) 1996-08-01
KR100225010B1 (ko) 1999-10-15
DE4122706C1 (enExample) 1993-03-04
JPH085796B2 (ja) 1996-01-24
ATE139446T1 (de) 1996-07-15
RU2072859C1 (ru) 1997-02-10
IL102410A (en) 1998-02-22
JPH0753392A (ja) 1995-02-28
AU1937092A (en) 1993-01-14
UA26971C2 (uk) 2000-02-28
CZ214392A3 (en) 1993-02-17
CA2072950A1 (en) 1993-01-10
SK214392A3 (en) 1994-11-09
ZA925059B (en) 1993-04-28
HUT61668A (en) 1993-03-01
IE74691B1 (en) 1997-07-30
MD1139F2 (en) 1999-01-31
YU48554B (sh) 1998-11-05
KR930001926A (ko) 1993-02-22
SI9200138A (en) 1993-03-31
YU67492A (sr) 1996-01-09
US5308619A (en) 1994-05-03
MD950171A (en) 1996-06-28
AU652262B2 (en) 1994-08-18
EP0535317B1 (de) 1996-06-19
SK279531B6 (sk) 1998-12-02
PT100668A (pt) 1993-09-30
HU9202274D0 (en) 1992-10-28
DK0535317T3 (da) 1996-07-15
EP0535317A1 (de) 1993-04-07
CZ279915B6 (cs) 1995-08-16
MX9204011A (es) 1993-07-01
IL102410A0 (en) 1993-01-14
DE59206608D1 (de) 1996-07-25

Similar Documents

Publication Publication Date Title
Bordoloi et al. Naturally occurring cadinenes
EP1016708A4 (en) YEAR EXTRACT COMPOSITION, YEAR FOR THE PRESERVATION OF THE SAME AND METHOD FOR THE PRODUCTION OF A YEAR EXTRACT COMPOSITION
IL95505A (en) Neuro-peptide containing erection-inducing compositions and use thereof
MD1139G2 (ro) Remediu farmaceutic şi utilizarea lui pentru ameliorarea sau suprimarea stărilor de excitare în disfuncţiile nervoase
JPS5423865A (en) Locking device of pin
Zimmerman Australian weevils
DK0541780T3 (enExample)
IL102801A (en) Process for extraction of antineoplastic substances from plants of the family palma, the subfamily phoenicoideae and the species phoenix and pharmaceutical preparations containing as active principle the above extracts
Cook Validation of a growth hormone radioimmunoassay and its application to neuroendocrine studies in the goldfish, Carassius auratus
KR940018036A (ko) 버섯추출물을 함유한 건강식품
Reinhold Classical Past and American Present: Ancient Values and Contemporary Issues in the Classroom
姚尊华 TREATMENT OF TRICHOMONAL ENTERITIS BY CHINESE MEDICINAL HERBS——REPORT OF 16 CASES
BG49742A1 (en) Affrodisiance means
DE3366647D1 (en) Ruscus extract, process for its preparation, and its use as a veinotonically active principle
DE29504471U1 (de) Kräuterlikör
Roberts et al. The effects of grassland improvement on the quality of upland streamflow-a'natural'lysimeter and small plot experiment on Plynlimon, mid-Wales
Cellini et al. Topical allergy induced by administration of timolol maleate.
GEP19981157B (en) Method of treatment of ulcero-necrotic stomatitis
Cormier Effects of training on alcoholic clients' self-disclosure in group counselling
松井貴至 Quantitative Anayisis of Edema in the Dorsal Nerve Roots Induced by Acute Mechanical Compression
SE7411918L (enExample)
Briggs et al. Comfrey: Risk and benefit
RU96108993A (ru) Композиция ингредиентов для водки особой "300 лет российскому флоту"
IE780730L (en) Veterinary composition
唐质灿 et al. A NEW SPECIES OF THE GENUS SYMPLECTOSCYPHUS (HYDROIDA) FROM THE HUANGHAI SEA